123 related articles for article (PubMed ID: 16085057)
1. Alsin is partially associated with centrosome in human cells.
Millecamps S; Gentil BJ; Gros-Louis F; Rouleau G; Julien JP
Biochim Biophys Acta; 2005 Aug; 1745(1):84-100. PubMed ID: 16085057
[TBL] [Abstract][Full Text] [Related]
2. The first ALS2 missense mutation associated with JPLS reveals new aspects of alsin biological function.
Panzeri C; De Palma C; Martinuzzi A; Daga A; De Polo G; Bresolin N; Miller CC; Tudor EL; Clementi E; Bassi MT
Brain; 2006 Jul; 129(Pt 7):1710-9. PubMed ID: 16670179
[TBL] [Abstract][Full Text] [Related]
3. Molecular and cellular function of ALS2/alsin: implication of membrane dynamics in neuronal development and degeneration.
Hadano S; Kunita R; Otomo A; Suzuki-Utsunomiya K; Ikeda JE
Neurochem Int; 2007; 51(2-4):74-84. PubMed ID: 17566607
[TBL] [Abstract][Full Text] [Related]
4. Are alsin and spartin novel interaction partners?
Çobanoğlu G; Ozansoy M; Başak AN
Biochem Biophys Res Commun; 2012 Oct; 427(1):1-4. PubMed ID: 22982304
[TBL] [Abstract][Full Text] [Related]
5. Absence of alsin function leads to corticospinal motor neuron vulnerability via novel disease mechanisms.
Gautam M; Jara JH; Sekerkova G; Yasvoina MV; Martina M; Özdinler PH
Hum Mol Genet; 2016 Mar; 25(6):1074-87. PubMed ID: 26755825
[TBL] [Abstract][Full Text] [Related]
6. Alsin is a Rab5 and Rac1 guanine nucleotide exchange factor.
Topp JD; Gray NW; Gerard RD; Horazdovsky BF
J Biol Chem; 2004 Jun; 279(23):24612-23. PubMed ID: 15033976
[TBL] [Abstract][Full Text] [Related]
7. Astrocytic protection of spinal motor neurons but not cortical neurons against loss of Als2/alsin function.
Jacquier A; Bellouze S; Blanchard S; Bohl D; Haase G
Hum Mol Genet; 2009 Jun; 18(12):2127-39. PubMed ID: 19304783
[TBL] [Abstract][Full Text] [Related]
8. Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene.
Eymard-Pierre E; Lesca G; Dollet S; Santorelli FM; di Capua M; Bertini E; Boespflug-Tanguy O
Am J Hum Genet; 2002 Sep; 71(3):518-27. PubMed ID: 12145748
[TBL] [Abstract][Full Text] [Related]
9. Alsin and the molecular pathways of amyotrophic lateral sclerosis.
Chandran J; Ding J; Cai H
Mol Neurobiol; 2007 Dec; 36(3):224-31. PubMed ID: 17955197
[TBL] [Abstract][Full Text] [Related]
10. Infantile-onset ascending hereditary spastic paraplegia with bulbar involvement due to the novel ALS2 mutation c.2761C>T.
Wakil SM; Ramzan K; Abuthuraya R; Hagos S; Al-Dossari H; Al-Omar R; Murad H; Chedrawi A; Al-Hassnan ZN; Finsterer J; Bohlega S
Gene; 2014 Feb; 536(1):217-20. PubMed ID: 24315819
[TBL] [Abstract][Full Text] [Related]
11. ALS2/alsin knockout mice and motor neuron diseases.
Cai H; Shim H; Lai C; Xie C; Lin X; Yang WJ; Chandran J
Neurodegener Dis; 2008; 5(6):359-66. PubMed ID: 18714162
[TBL] [Abstract][Full Text] [Related]
12. Alsin, the product of ALS2 gene, suppresses SOD1 mutant neurotoxicity through RhoGEF domain by interacting with SOD1 mutants.
Kanekura K; Hashimoto Y; Niikura T; Aiso S; Matsuoka M; Nishimoto I
J Biol Chem; 2004 Apr; 279(18):19247-56. PubMed ID: 14970233
[TBL] [Abstract][Full Text] [Related]
13. Altered oligomeric states in pathogenic ALS2 variants associated with juvenile motor neuron diseases cause loss of ALS2-mediated endosomal function.
Sato K; Otomo A; Ueda MT; Hiratsuka Y; Suzuki-Utsunomiya K; Sugiyama J; Murakoshi S; Mitsui S; Ono S; Nakagawa S; Shang HF; Hadano S
J Biol Chem; 2018 Nov; 293(44):17135-17153. PubMed ID: 30224357
[TBL] [Abstract][Full Text] [Related]
14. Alsin/Rac1 signaling controls survival and growth of spinal motoneurons.
Jacquier A; Buhler E; Schäfer MK; Bohl D; Blanchard S; Beclin C; Haase G
Ann Neurol; 2006 Jul; 60(1):105-17. PubMed ID: 16802292
[TBL] [Abstract][Full Text] [Related]
15. Genotype-phenotype correlation in seven motor neuron disease families with novel ALS2 mutations.
Sprute R; Jergas H; Ölmez A; Alawbathani S; Karasoy H; Dafsari HS; Becker K; Daimagüler HS; Nürnberg P; Muntoni F; Topaloglu H; Uyanik G; Cirak S
Am J Med Genet A; 2021 Feb; 185(2):344-354. PubMed ID: 33155358
[TBL] [Abstract][Full Text] [Related]
16. Amyotrophic lateral sclerosis 2-deficiency leads to neuronal degeneration in amyotrophic lateral sclerosis through altered AMPA receptor trafficking.
Lai C; Xie C; McCormack SG; Chiang HC; Michalak MK; Lin X; Chandran J; Shim H; Shimoji M; Cookson MR; Huganir RL; Rothstein JD; Price DL; Wong PC; Martin LJ; Zhu JJ; Cai H
J Neurosci; 2006 Nov; 26(45):11798-806. PubMed ID: 17093100
[TBL] [Abstract][Full Text] [Related]
17. Biochemical characterization of Alsin, a Rab5 and Rac1 guanine nucleotide exchange factor.
Topp JD; Carney DS; Horazdovsky BF
Methods Enzymol; 2005; 403():261-76. PubMed ID: 16473593
[TBL] [Abstract][Full Text] [Related]
18. Regulation of endosomal motility and degradation by amyotrophic lateral sclerosis 2/alsin.
Lai C; Xie C; Shim H; Chandran J; Howell BW; Cai H
Mol Brain; 2009 Jul; 2():23. PubMed ID: 19630956
[TBL] [Abstract][Full Text] [Related]
19. ALS2, a novel guanine nucleotide exchange factor for the small GTPase Rab5, is implicated in endosomal dynamics.
Otomo A; Hadano S; Okada T; Mizumura H; Kunita R; Nishijima H; Showguchi-Miyata J; Yanagisawa Y; Kohiki E; Suga E; Yasuda M; Osuga H; Nishimoto T; Narumiya S; Ikeda JE
Hum Mol Genet; 2003 Jul; 12(14):1671-87. PubMed ID: 12837691
[TBL] [Abstract][Full Text] [Related]
20. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis.
Yang Y; Hentati A; Deng HX; Dabbagh O; Sasaki T; Hirano M; Hung WY; Ouahchi K; Yan J; Azim AC; Cole N; Gascon G; Yagmour A; Ben-Hamida M; Pericak-Vance M; Hentati F; Siddique T
Nat Genet; 2001 Oct; 29(2):160-5. PubMed ID: 11586297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]